Can PTSD be effectively treated? Until about 5 years ago, we had only a limited appreciation of how effective treatment could be. What little we knew led us to believe that gains were only modest and treatment largely palliative. More recent reports of trials assessing selective serotonin reuptake inhibitors and exposure-based psychosocial therapies have fortunately painted a much brighter picture, and it is now justifiable, indeed best practice, to think of remission as the desired outcome (
+4,
+5). It is also important to keep in mind that most survivors of trauma do not develop PTSD. Could innate human resilience have a protective effect? Is it possible to promote resilience with our known effective treatments? Evidence suggests that this may be so (
+4). The articles presented in this edition of
Focus serve as timely elaborations on these themes.